Washington, DC-The ophthalmic community is seeing the fruits of its labor with the U.S. House passage of the "Medicare Prescription Drug and Modernization Act of 2003." The act calls for Medicare physician updates of at least 1.5% in 2004 and 2005.
ChatGPT may have a future use in glaucoma
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
Therapeutic in development to take on diabetic macular edema
Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention
Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410
Stress resilience–enhancing drugs: New class of small molecules holds promise